You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 16, April 28, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina

Since this article does not have an abstract, we have provided the first 79 words of the full text and any section headings.

To the Editor: Dr Chaitman and colleagues1 did not present detailed safety data. In particular, we would be interested in knowing the effect ranolazine has on kidneys, liver, blood cells, or metabolism, as well as on quality of life and hospital admission rates. Furthermore, the authors reported that 30% to 41% of subjects stopped taking ranolazine, but they did not present their subsequent clinical events. The fate of these individuals is critical in assessing the safety of this drug.

Christoph Pechlaner, MD
christoph.pechlaner@uibk.ac.at
Innsbruck University Hospital
Innsbruck, Austria

Christian Wiedermann, MD
General Hospital of Bolzano
Bolzano, Italy

1. Chaitman BR, Pepine CJ, Parker JO, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA. 2004;291:309-316. FREE FULL TEXT

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291:1959.


RELATED ARTICLES

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina
Justin S. Hooper and Anthony J. Busti
JAMA. 2004;291(16):1959.
EXTRACT | FULL TEXT  

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina—Reply
Bernard R. Chaitman
JAMA. 2004;291(16):1959-1960.
EXTRACT | FULL TEXT  

Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina: A Randomized Controlled Trial
Bernard R. Chaitman, Carl J. Pepine, John O. Parker, Jaroslav Skopal, Galina Chumakova, Jerzy Kuch, Whedy Wang, Sandra L. Skettino, and Andrew A. Wolff
JAMA. 2004;291(3):309-316.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.